KLTO Klotho Neurosciences, Inc.

Nasdaq klothoneuro.com


$ 0.47 $ 0.01 (2.67 %)    

Friday, 14-Nov-2025 09:40:02 EST
QQQ $ 605.15 $ 5.52 (0.92 %)
DIA $ 470.88 $ -0.54 (-0.11 %)
SPY $ 669.12 $ 3.67 (0.55 %)
TLT $ 89.24 $ -0.55 (-0.61 %)
GLD $ 375.11 $ 2.22 (0.6 %)
$ 0.475
$ 0.45
$ 0.48 x 3
$ 0.48 x 1,000
$ 0.45 - $ 0.47
$ 0.11 - $ 3.91
392,839
na
34.45M
$ 0.81
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2025 09-30-2025 10-Q
2 08-18-2025 06-30-2025 10-Q
3 05-14-2025 03-31-2025 10-Q
4 03-31-2025 12-31-2024 10-K
5 11-19-2024 09-30-2024 10-Q
6 08-19-2024 06-30-2024 10-Q
7 05-23-2024 03-31-2024 10-Q
8 04-17-2024 12-31-2023 10-K
9 08-21-2023 06-30-2023 10-Q
10 05-24-2023 03-31-2023 10-Q
11 04-10-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Klotho Neurosciences (NASDAQ:KLTO) reported quarterly losses of $(0.05) per share. This is a 72.22 percent increase over losses...

Core News & Articles

Klotho Neurosciences (NASDAQ:KLTO) reported quarterly losses of $(0.12) per share. This is a 300 percent decrease over losses o...

Core News & Articles

Key partnerships, regulatory  progress, manufacturing advancements, along with significant capital infusion accelerate the deve...

Core News & Articles

Company to Pursue Technologies to Improve Muscle Strength, Bone Health, and Other Longevity IndicatorsNEW YORK, July 24, 2025 /...

Core News & Articles

-SEC Filing

 klotho-clears-nasdaq-hurdleklto-stock-remains-on-the-big-board

Klotho Neurosciences' stock has full compliance with all continued listing requirements and will remain listed and traded o...

Core News & Articles

Klotho Neurosciences, Inc. ("Klotho" or the "Company") (NASDAQ: KLTO), a gene and cell therapy company focused ...

 klotho-stock-delivers-1222-biotech-blowout-opportunity-or-bubble

Klotho shares have soared more than 1000% over the past three months on promising results and breakthrough hopes.

 us-stocks-likely-to-open-lower-a-day-after-nasdaq-hits-record-high-nvidia-kellogg-klotho-in-focus

U.S. stock futures declined on Thursday after ending higher on Wednesday. Futures of major benchmark indices were trading lower.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION